rsv

Documents about rsv

• RSV Vaccination in Immunocompromised Patients.#1009558ClinicalTrials.gov
• Assessing the Burden of Respiratory Syncytial Virus (RSV)#1422130ClinicalTrials.gov
• Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis#5394Europe PMC
• RSV Vaccine Pregnancy Registry#1074932ClinicalTrials.gov
• Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults#1125526ClinicalTrials.gov
• Artificial Intelligence-assisted Primary Care for RSV Prevention (AIPC-RSV) in China#1228269ClinicalTrials.gov
• Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults#180215ClinicalTrials.gov
• Real-World Effectiveness of Perinatal RSV Immunoprophylaxis#854577ClinicalTrials.gov
• Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)#234474ClinicalTrials.gov
• RSV Immunogenicity Study in the Elderly (RISE)#1126989ClinicalTrials.gov
• Disease Burden of RSV#1432446ClinicalTrials.gov
• Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children#896160ClinicalTrials.gov
• Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination#180213ClinicalTrials.gov
• Systems Biological Analysis of Immune Responses to RSV Vaccine#860262ClinicalTrials.gov
• Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age#1485877ClinicalTrials.gov
• Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants#1339271ClinicalTrials.gov
• Effect of Heliox on RSV Bronchiolitis#909282ClinicalTrials.gov
• Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children#851118ClinicalTrials.gov
• RESCEU Study, Defining the Burden of Disease of RSV in Older Adults#826040ClinicalTrials.gov
• A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model#1161611ClinicalTrials.gov
• Severity of RSV Infections in Twins#1439908ClinicalTrials.gov
• Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine#154737ClinicalTrials.gov
• Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns#1112218ClinicalTrials.gov
• Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection#1161746ClinicalTrials.gov
• Stakeholder-Informed RSV Prevention Economic Model in Botswana#1095399ClinicalTrials.gov
• Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)#195376ClinicalTrials.gov
• Safety and Immunogenicity Study of SCB-1019T in Children#827514ClinicalTrials.gov
• COVID-19 Impact on RSV Emergency Presentations#1059893ClinicalTrials.gov
• Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis#917876ClinicalTrials.gov
• Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years#1418784ClinicalTrials.gov
• A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants#125948ClinicalTrials.gov
• Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic#895247ClinicalTrials.gov
• Anti-RSV Study in Chinese Patients (ASCENT)#900475ClinicalTrials.gov
• Safety Study of Oral BTA9881 to Treat RSV Infection#1465573ClinicalTrials.gov
• Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study#1475029ClinicalTrials.gov
• BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)#917025ClinicalTrials.gov
• Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults#1198446ClinicalTrials.gov
• Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis#1438037ClinicalTrials.gov
• A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness#805555ClinicalTrials.gov
• A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults#864729ClinicalTrials.gov
• A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model#981283ClinicalTrials.gov
• A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age#895750ClinicalTrials.gov
• Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children#1430378ClinicalTrials.gov
• Infant RSV Infections and Health-related Quality of Life of Families#1445845ClinicalTrials.gov
• Public surveillance early warning for older-adult influenza/RSV hospitalization burden#11940DataCite
• A Study of ALS-008176 in Infants Hospitalized With RSV#857350ClinicalTrials.gov
• Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control#981914ClinicalTrials.gov
• Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection#1151662ClinicalTrials.gov
• Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan#1323396ClinicalTrials.gov
• ayakamon/BR-RSV-MV#257891LSHTM Data Compass